Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 343

1.

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection.

Real LM, Macías J, Rivero-Juárez A, Téllez F, Merino D, Moreno-Grau S, Orellana A, Gómez-Salgado J, Sáez ME, Frías M, Corma-Gómez A, Merchante N, Ruiz A, Caruz A, Pineda JA; GEHEP 012 study group.

Sci Rep. 2019 Jun 21;9(1):9054. doi: 10.1038/s41598-019-45389-4.

2.

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection.

Brochado-Kith Ó, Gómez Sanz A, Real LM, Crespo García J, Ryan Murúa P, Macías J, Cabezas González J, Troya J, Pineda JA, Arias Loste MT, Díez Viñas V, Jiménez-Sousa MÁ, Medrano de Dios LM, Cuesta De la Plaza I, Monzón Fernández S, Resino García S, Fernández-Rodríguez A.

J Clin Med. 2019 Jun 14;8(6). pii: E849. doi: 10.3390/jcm8060849.

3.

A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study).

Real LM, Fernández-Fuertes M, Sáez ME, Rivero-Juárez A, Frías M, Téllez F, Santos J, Merino D, Moreno-Grau S, Gómez-Salgado J, González-Serna A, Corma-Gómez A, Ruiz A, Macías J, Pineda JA.

Liver Int. 2019 Jun 17. doi: 10.1111/liv.14177. [Epub ahead of print]

PMID:
31206233
4.

Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by Mammalian Target of Rapamycin Complex 2 in Bladder Cancer Cells.

Hau AM, Gupta S, Leivo MZ, Nakashima K, Macias J, Zhou W, Hodge A, Wulfkuhle J, Conkright B, Bhuvaneshwar K, Rao S, Madhavan S, Petricoin EF 3rd, Hansel DE.

Am J Pathol. 2019 Sep;189(9):1846-1862. doi: 10.1016/j.ajpath.2019.05.010. Epub 2019 Jun 11.

PMID:
31199921
5.

Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks.

Corma-Gómez A, Macías J, Merino Muñoz D, Téllez F, Granados R, Morano LE, De Los Santos Gil I, Vera-Méndez FJ, Collado A, Palacios R, Pineda JA.

J Infect. 2019 Jul;79(1):30-35. doi: 10.1016/j.jinf.2019.05.005. Epub 2019 May 14.

PMID:
31100364
6.

Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients.

Rivero-Juarez A, Tellez F, Castaño-Carracedo M, Merino D, Espinosa N, Santos J, Macias J, Paniagua-García M, Zapata-Lopez A, Collado A, Gómez-Vidal MA, Perez-Stachowski J, Muñoz-Medina L, Fernandez-Fuertes E, Rivero A; Grupo de estudio de Hepatitis virales (HEPAVIR) of the Sociedad Andaluza de Enfermedades Infecciosas (SAEI).

HIV Med. 2019 Jul;20(6):359-367. doi: 10.1111/hiv.12715. Epub 2019 Apr 22.

PMID:
31006980
7.

The simplification of the diagnosis process of chronic hepatitis C is cost-effective strategy.

García F, Domínguez-Hernández R, Casado M, Macías J, Téllez F, Pascasio JM, Casado MÁ, Alados JC.

Enferm Infecc Microbiol Clin. 2019 Apr 11. pii: S0213-005X(19)30143-0. doi: 10.1016/j.eimc.2019.03.001. [Epub ahead of print] English, Spanish.

PMID:
30982677
8.

Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation.

Haydar S, Grigorescu F, Vintilă M, Cogne Y, Lautier C, Tutuncu Y, Brun JF, Robine JM, Pugeat M, Normand C, Poucheret P, Gheorghiu ML, Georgescu C, Badiu C, Băculescu N, Renard E, Ylli D, Badiou S, Sutra T, Cristol JP, Mercier J, Gomis R, Macias JM, Litvinov S, Khusnutdinova E, Poiana C, Pasquali R, Lauro D, Sesti G, Prudente S, Trischitta V, Tsatsoulis A, Abdelhak S, Barakat A, Zenati A, Ylli A, Satman I, Kanninen T, Rinato Y, Missoni S.

PLoS One. 2019 Mar 26;14(3):e0214122. doi: 10.1371/journal.pone.0214122. eCollection 2019.

9.

Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy.

Macías J, Morano LE, Téllez F, Granados R, Rivero-Juárez A, Palacios R, Ríos M, Merino D, Pérez-Pérez M, Collado A, Figueruela B, Morano A, Freyre-Carrillo C, Martín JM, Rivero A, García F, Pineda JA; HEPAVIR group from the Sociedad Andaluza de Enfermedades Infecciosas (SAEI) and the GEHEP group from the Sociedad Española de Enfermedades Infecciosas y Microbiología (SEIMC).

J Hepatol. 2019 Jul;71(1):45-51. doi: 10.1016/j.jhep.2019.02.018. Epub 2019 Mar 8.

PMID:
30853642
10.

HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals.

Corma-Gómez A, Morano L, Téllez F, Rivero-Juárez A, Real LM, Alados JC, Ríos-Villegas MJ, Vera-Méndez FJ, Muñoz RP, Geijo P, Macías J, Pineda JA; RIS-HEP13 and GEHEP 011 study groups.

AIDS. 2019 Jun 1;33(7):1167-1174. doi: 10.1097/QAD.0000000000002186.

PMID:
30845068
11.

RECQL5: Another DNA helicase potentially involved in hereditary breast cancer susceptibility.

Tavera-Tapia A, de la Hoya M, Calvete O, Martin-Gimeno P, Fernández V, Macías JA, Alonso B, Pombo L, de Diego C, Alonso R, Pita G, Barroso A, Urioste M, Caldés T, Newman JA, Benítez J, Osorio A.

Hum Mutat. 2019 May;40(5):566-577. doi: 10.1002/humu.23732. Epub 2019 Mar 13.

PMID:
30817846
12.

The efficacy of functional-analytic psychotherapy and acceptance and commitment therapy (FACT) for public employees.

Macías J, Valero-Aguayo L, Bond FW, Blanca MJ.

Psicothema. 2019 Feb;31(1):24-29. doi: 10.7334/psicothema2018.202.

PMID:
30664407
13.

Epidemiology of Strongyloides stercoralis infection in Bolivian patients at high risk of complications.

Gétaz L, Castro R, Zamora P, Kramer M, Gareca N, Torrico-Espinoza MDC, Macias J, Lisarazu-Velásquez S, Rodriguez G, Valencia-Rivero C, Perneger T, Chappuis F.

PLoS Negl Trop Dis. 2019 Jan 17;13(1):e0007028. doi: 10.1371/journal.pntd.0007028. eCollection 2019 Jan.

14.

Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder.

Roncero C, Ryan P, Littlewood R, Macías J, Ruiz J, Seijo P, Palma-Álvarez RF, Vega P.

Hepat Med. 2018 Dec 24;11:1-11. doi: 10.2147/HMER.S187133. eCollection 2019.

15.

Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users.

Pineda JA, Climent B, García F, García Deltoro M, Granados R, Gómez F, Macías J, Mena Á, Merchante N, Ochoa E, Roncero C, Ruiz JJ, Téllez F, Morano L.

Enferm Infecc Microbiol Clin. 2018 Nov 8. pii: S0213-005X(18)30266-0. doi: 10.1016/j.eimc.2018.09.006. [Epub ahead of print] English, Spanish.

PMID:
30415884
16.

Associated risk factors influencing ovine Eimeria infections in southern Spain.

Carrau T, Silva LMR, Pérez D, Failing K, Martínez-Carrasco C, Macías J, Taubert A, Hermosilla C, de Ybáñez RR.

Vet Parasitol. 2018 Nov 15;263:54-58. doi: 10.1016/j.vetpar.2018.10.004. Epub 2018 Oct 6.

PMID:
30389025
17.

Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients.

Merchante N, Figueruela B, Rodríguez-Fernández M, Rodríguez-Arrondo F, Revollo B, Ibarra S, Galindo MJ, Merino E, Montero M, Téllez F, García-Deltoro M, Rivero-Juárez A, Delgado-Fernández M, Ríos-Villegas MJ, Aguirrebengoa K, García MA, Portu J, Vera-Méndez FJ, Villalobos M, Mínguez C, De Los Santos I, López-Ruz MA, Omar M, Galera C, Macias J, Pineda JA; GEHEP-002 Study Group.

AIDS. 2019 Feb 1;33(2):269-278. doi: 10.1097/QAD.0000000000002065.

PMID:
30325782
18.

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life.

Real LM, Macías J, Pérez AB, Merino D, Granados R, Morano L, Delgado M, Ríos MJ, Galera C, Deltoro MG, Merchante N, García F, Pineda JA.

Sci Rep. 2018 Oct 8;8(1):14905. doi: 10.1038/s41598-018-33367-1.

19.

Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries.

Pessoa de Magalhães Filho RJ, Crusoe E, Riva E, Bujan W, Conte G, Navarro Cabrera JR, Garcia DK, Vega GQ, Macias J, Oliveros Alvear JW, Royg M, Neves LA, Lopez Dopico JL, Espino G, Ortiz DR, Socarra Z, Fantl D, Ruiz-Arguelles GJ, Maiolino A, Hungria VTM, Harousseau JL, Durie B.

Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):e43-e50. doi: 10.1016/j.clml.2018.08.005. Epub 2018 Aug 29.

PMID:
30297171
20.

Compromising Between Phase Stability and Electrical Performance: SrVO3 -SrTiO3 Solid Solutions as Solid Oxide Fuel Cell Anode Components.

Macías J, Yaremchenko AA, Rodríguez-Castellón E, Starykevich M, Frade JR.

ChemSusChem. 2019 Jan 10;12(1):240-251. doi: 10.1002/cssc.201801727. Epub 2018 Nov 20.

PMID:
30281934
21.

Branched-Chain Amino Acid Database Integrated in MEDIPAD Software as a Tool for Nutritional Investigation of Mediterranean Populations.

Haydar S, Paillot T, Fagot C, Cogne Y, Fountas A, Tutuncu Y, Vintila M, Tsatsoulis A, Thanh Chi P, Garandeau P, Chetea D, Badiu C, Gheorghiu M, Ylli D, Lautier C, Jarec M, Monnier L, Normand C, Šarac J, Barakat A, Missoni S, Pugeat M, Poucheret P, Hanzu F, Gomis R, Macias JM, Litvinov S, Khusnutdinova E, Poiana C, Pasquali R, Lauro D, Sesti G, Trischitta V, Abdelhak S, Zenati A, Ylli A, Satman I, Kanninen T, Rinato Y, Grigorescu F.

Nutrients. 2018 Oct 1;10(10). pii: E1392. doi: 10.3390/nu10101392.

22.

Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH).

Calleja JL, Macias J, Forns X, Garcia F, Berenguer M, Garcia Deltoro M, Buti M, Granados R, Carrion JA, Morano L, Fernandez I, Coste P, Pineda JA.

Gastroenterol Hepatol. 2018 Nov;41(9):597-608. doi: 10.1016/j.gastrohep.2018.07.010. Epub 2018 Sep 27. English, Spanish. No abstract available.

PMID:
30270150
23.

Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients.

Macías J, Téllez F, Rivero-Juárez A, Palacios R, Morano LE, Merino D, Collado A, García-Fraile L, Omar M, Pineda JA; the HEPAVIR, GEHEP and RIS-HEP07 study groups.

J Viral Hepat. 2019 Jan;26(1):48-54. doi: 10.1111/jvh.13003. Epub 2018 Oct 17.

PMID:
30199593
24.

Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection.

Macías J, Granados R, Téllez F, Merino D, Pérez M, Morano LE, Palacios R, Paniagua M, Frías M, Merchante N, Pineda JA; HEPAVIR GEHEP, RIS-HEP07 study groups.

J Viral Hepat. 2019 Jan;26(1):16-24. doi: 10.1111/jvh.12990. Epub 2018 Sep 27.

PMID:
30141222
25.

Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

Rivero-Juárez A, Aguilera A, Avellón A, García-Deltoro M, García F, Gortazar C, Granados R, Macías J, Merchante N, Oteo JA, Pérez-Gracia MT, Pineda JA, Rivero A, Rodriguez-Lazaro D, Téllez F, Morano-Amado LE; Grupo redactor de GeHEP SEIMC.

Enferm Infecc Microbiol Clin. 2018 Jul 30. pii: S0213-005X(18)30227-1. doi: 10.1016/j.eimc.2018.06.014. [Epub ahead of print] English, Spanish.

PMID:
30072282
26.

Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis.

Merchante N, Rivero-Juárez A, Téllez F, Merino D, Ríos-Villegas MJ, Villalobos M, Omar M, Rincón P, Rivero A, Pérez-Pérez M, Raffo M, López-Montesinos I, Palacios R, Gómez-Vidal MA, Macías J, Pineda JA; Members of the HEPAVIR-Cirrhosis Study Group .

J Antimicrob Chemother. 2018 Sep 1;73(9):2435-2443. doi: 10.1093/jac/dky234.

PMID:
29982683
27.

Monte Carlo verification of radiotherapy treatments with CloudMC.

Miras H, Jiménez R, Perales Á, Terrón JA, Bertolet A, Ortiz A, Macías J.

Radiat Oncol. 2018 Jun 27;13(1):99. doi: 10.1186/s13014-018-1051-9.

28.

Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care.

McCombe G, Swan D, O'Connor E, Avramovic G, Vickerman P, Ward Z, Surey J, Macías J, Lambert JS, Cullen W.

JMIR Res Protoc. 2018 Jun 4;7(6):e149. doi: 10.2196/resprot.9043.

29.

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients.

Merchante N, Rodríguez-Arrondo F, Revollo B, Merino E, Ibarra S, Galindo MJ, Montero M, García-Deltoro M, Rivero-Juárez A, Téllez F, Delgado-Fernández M, Ríos-Villegas MJ, García MA, Vera-Méndez FJ, Ojeda-Burgos G, López-Ruz MA, Metola L, Omar M, Alemán-Valls MR, Aguirrebengoa K, Portu J, Raffo M, Macías J, Pineda JA; GEHEP-002 Study Group.

AIDS. 2018 Jul 17;32(11):1423-1430. doi: 10.1097/QAD.0000000000001809.

PMID:
29596108
30.

Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice.

Pineda JA, Rivero-Juárez A, de Los Santos I, Collado A, Merino D, Morano-Amado LE, Ríos MJ, Pérez-Pérez M, Téllez F, Palacios R, Pérez AB, Mancebo M, Rivero A, Macías J.

HIV Clin Trials. 2018 Feb;19(1):23-30. doi: 10.1080/15284336.2018.1436637. Epub 2018 Feb 15.

PMID:
29447085
31.

Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort.

Álvarez-Ossorio MJ, Sarmento E Castro R, Granados R, Macías J, Morano-Amado LE, Ríos MJ, Merino D, Álvarez EN, Collado A, Pérez-Pérez M, Téllez F, Martín JM, Méndez J, Pineda JA, Neukam K; HEPAVIR-DAA, GEHEP-MONO, RIS-HEP07 and RIS-HEP13 Study Groups.

J Viral Hepat. 2018 Jun;25(6):699-706. doi: 10.1111/jvh.12867. Epub 2018 Feb 27.

PMID:
29377515
32.

Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol.

Swan D, Cullen W, Macias J, Oprea C, Story A, Surey J, Vickerman P, Lambert JS.

Expert Rev Gastroenterol Hepatol. 2018 Mar;12(3):303-314. doi: 10.1080/17474124.2018.1424541. Epub 2018 Jan 16.

PMID:
29300496
33.

Structure of the Bacillus anthracis dTDP-L-rhamnose-biosynthetic enzyme dTDP-4-dehydrorhamnose 3,5-epimerase (RfbC).

Shornikov A, Tran H, Macias J, Halavaty AS, Minasov G, Anderson WF, Kuhn ML.

Acta Crystallogr F Struct Biol Commun. 2017 Dec 1;73(Pt 12):664-671. doi: 10.1107/S2053230X17015849. Epub 2017 Nov 10.

34.

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.

Macías J, Mancebo M, Merino D, Téllez F, Montes-Ramírez ML, Pulido F, Rivero-Juárez A, Raffo M, Pérez-Pérez M, Merchante N, Cotarelo M, Pineda JA; Spanish AIDS Research Network-HEP09 Study Group.

Clin Infect Dis. 2017 Sep 15;65(6):1012-1019. doi: 10.1093/cid/cix467.

PMID:
28903510
35.

Automated assembly of species metabolomes through data submission into a public repository.

Salek RM, Conesa P, Cochrane K, Haug K, Williams M, Kale N, Moreno P, Jayaseelan KV, Macias JR, Nainala VC, Hall RD, Reed LK, Viant MR, O'Donovan C, Steinbeck C.

Gigascience. 2017 Aug 1;6(8):1-4. doi: 10.1093/gigascience/gix062.

36.

Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients.

Merchante N, Aldámiz-Echevarría T, García-Álvarez M, Rivero-Juárez A, Macías J, Miralles P, Jiménez-Sousa MA, Mancebo M, Pérez-Latorre L, Pineda-Tenor D, Berenguer J, Resino S, Pineda JA.

J Viral Hepat. 2018 Feb;25(2):180-186. doi: 10.1111/jvh.12769. Epub 2017 Sep 7.

PMID:
28783247
37.

Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals.

Arboledas JCA, Guerrero IP, Rodríguez MJB, Martos ET, Pérez AB, León CC, Sierra Sánchez JF, Prieto MDL, Porcuna NC, Mochón MDO, Macías J, de la Iglesia Salgado A, Granger JR, Fernández MD, Lozano IG, Ramírez ER, Rivero A, Del Carmen Lozano Domínguez M, Viciana I, Montemayor JCG, García FG.

Diagn Microbiol Infect Dis. 2017 Sep;89(1):29-34. doi: 10.1016/j.diagmicrobio.2017.06.006. Epub 2017 Jun 17.

PMID:
28669680
38.

Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m2): a summary document from the European Renal Best Practice Group.

Farrington K, Covic A, Nistor I, Aucella F, Clyne N, De Vos L, Findlay A, Fouque D, Grodzicki T, Iyasere O, Jager KJ, Joosten H, Macias JF, Mooney A, Nagler E, Nitsch D, Taal M, Tattersall J, Stryckers M, van Asselt D, Van den Noortgate N, van der Veer S, van Biesen W.

Nephrol Dial Transplant. 2017 Jan 1;32(1):9-16. doi: 10.1093/ndt/gfw411.

39.

A rare cause of blood clots in blood bag.

Bejarano N, Macías J, Sanz C, Pereira A.

Transfus Med. 2017 Jun;27(3):231-232. doi: 10.1111/tme.12396. Epub 2017 Feb 24. No abstract available.

PMID:
28233920
40.

Non-Alcoholic Fatty Liver Disease in HIV Infection.

Macías J, Pineda JA, Real LM.

AIDS Rev. 2017 Jan-Mar;19(1):35-46. Review.

PMID:
28182612
41.

Low incidence of acute hepatitis C virus infection among Southern Spanish HIV-infected individuals.

Mancebo M, Macías J, Merchante N, Real LM, Lozano F, Domínguez L, Álvarez-Ossorio MJ, Saussol F, Rincón P, Pineda JA, Neukam K.

J Infect. 2017 May;74(5):514-517. doi: 10.1016/j.jinf.2017.01.013. Epub 2017 Feb 3. No abstract available.

PMID:
28167123
42.

Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection.

Pineda JA, Morano-Amado LE, Granados R, Macías J, Téllez F, García-Deltoro M, Ríos MJ, Collado A, Delgado-Fernández M, Suárez-Santamaría M, Serrano M, Miralles-Álvarez C, Neukam K; Grupo de Estudio de Hepatitis Vírica, of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica: GEHEP-SEIMC; Grupo de Estudio de Hepatitis Vírica, of the Sociedad Andaluza de Enfermedades Infecciosas y Microbiología Clínica: HEPAVIR / Red de Investigación en SIDA (RIS-HEP07).

Clin Microbiol Infect. 2017 Jun;23(6):409.e5-409.e8. doi: 10.1016/j.cmi.2016.12.034. Epub 2017 Jan 28.

43.

Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.

Núñez-Torres R, Macías J, Rivero-Juarez A, Neukam K, Merino D, Téllez F, Merchante N, Gómez-Mateos J, Rivero A, Pineda JA, Real LM; Group for the Study of Viral Hepatitis (HEPAVIR) of The Andalusian Society of Infectious Diseases (SAEI).

HIV Med. 2017 Sep;18(8):546-554. doi: 10.1111/hiv.12489. Epub 2017 Jan 24.

PMID:
28116842
44.

Isopropyl alcohol is as efficient as chlorhexidine to prevent contamination of blood cultures.

Martínez J, Macías JH, Arreguín V, Álvarez JA, Macías AE, Mosqueda-Gómez JL.

Am J Infect Control. 2017 Apr 1;45(4):350-353. doi: 10.1016/j.ajic.2016.11.027. Epub 2017 Jan 12.

PMID:
28089672
45.

Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients.

Neukam K, Morano-Amado LE, Rivero-Juárez A, Macías J, Granados R, Romero-Palacios A, Márquez M, Merino D, Ortega E, Alados-Arboledas JC, Cucurull J, Omar M, Ryan-Murua P, Pineda JA; Grupo de Estudio de Hepatitis Vírica, of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica: GEHEP-SEIMC and Grupo de Estudio de Hepatitis Vírica, of the Sociedad Andaluza de Enfermedades Infecciosas y Microbiología Clínica: HEPAVIR/Red de Investigación en SIDA (RIS-HEP07).

Eur J Clin Microbiol Infect Dis. 2017 May;36(5):853-861. doi: 10.1007/s10096-016-2871-x. Epub 2016 Dec 21.

PMID:
28004322
46.

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.

Núñez-Torres R, Macías J, Mancebo M, Frías M, Dolci G, Téllez F, Merino D, Merchante N, Gómez-Mateos J, Guaraldi G, Rivero-Juárez A, Pineda JA, Real LM; HEPAVIR-esteatosis Study Group.

PLoS One. 2016 Dec 14;11(12):e0168265. doi: 10.1371/journal.pone.0168265. eCollection 2016.

47.

Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis.

Merchante N, Rivero-Juárez A, Téllez F, Merino D, Ríos-Villegas MJ, Ojeda-Burgos G, Omar M, Macías J, Rivero A, Pérez-Pérez M, Raffo M, López-Montesinos I, Márquez-Solero M, Gómez-Vidal MA, Pineda JA; Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).

AIDS. 2017 Feb 20;31(4):493-500. doi: 10.1097/QAD.0000000000001358.

PMID:
27922855
48.

Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene.

Tavera-Tapia A, Pérez-Cabornero L, Macías JA, Ceballos MI, Roncador G, de la Hoya M, Barroso A, Felipe-Ponce V, Serrano-Blanch R, Hinojo C, Miramar-Gallart MD, Urioste M, Caldés T, Santillan-Garzón S, Benitez J, Osorio A.

Breast Cancer Res Treat. 2017 Feb;161(3):597-604. doi: 10.1007/s10549-016-4058-7. Epub 2016 Dec 2.

PMID:
27913932
49.

High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.

Macías J, Monge P, Mancebo M, Merchante N, Neukam K, Real LM, Pineda JA.

HIV Med. 2017 Aug;18(7):445-451. doi: 10.1111/hiv.12471. Epub 2016 Nov 24.

50.

Decontamination of stethoscope membranes with chlorhexidine: Should it be recommended?

Álvarez JA, Ruíz SR, Mosqueda JL, León X, Arreguín V, Macías AE, Macias JH.

Am J Infect Control. 2016 Nov 1;44(11):e205-e209. doi: 10.1016/j.ajic.2016.07.012. Epub 2016 Sep 7.

PMID:
27614707

Supplemental Content

Loading ...
Support Center